-
Not Just $N_e$ $N_e$-more: New Applications for SMC from Ecology to Phylogenies
Authors:
David Peede,
Trevor Cousins,
Arun Durvasula,
Anastasia Ignatieva,
Toby G. L. Kovacs,
Alba Nieto,
Emily E. Puckett,
Elizabeth T. Chevy
Abstract:
Genomes contain the mutational footprint of an organism's evolutionary history, shaped by diverse forces including ecological factors, selective pressures, and life history traits. The sequentially Markovian coalescent (SMC) is a versatile and tractable model for the genetic genealogy of a sample of genomes, which captures this shared history. Methods that utilize the SMC, such as PSMC and MSMC, h…
▽ More
Genomes contain the mutational footprint of an organism's evolutionary history, shaped by diverse forces including ecological factors, selective pressures, and life history traits. The sequentially Markovian coalescent (SMC) is a versatile and tractable model for the genetic genealogy of a sample of genomes, which captures this shared history. Methods that utilize the SMC, such as PSMC and MSMC, have been widely used in evolution and ecology to infer demographic histories. However, these methods ignore common biological features, such as gene flow events and structural variation. Recently, there have been several advancements that widen the applicability of SMC-based methods: inclusion of an isolation with migration model, integration with the multi-species coalescent, incorporation of ecological variables (such as selfing and dormancy), inference of dispersal rates, and many computational advances in applying these models to data. We give an overview of the SMC model and its various recent extensions, discuss examples of biological discoveries through SMC-based inference, and comment on the assumptions, benefits and drawbacks of various methods.
△ Less
Submitted 31 May, 2025;
originally announced June 2025.
-
Finite element simulation of the structural integrity of endothelial cell monolayers: a step for tumor cell extravasation
Authors:
A. Nieto,
J. Escribano,
F. Spill,
J. M. Garcia-Aznar,
M. J. Gomez-Benito
Abstract:
Cell extravasation is a crucial step of the metastatic cascade. In this process, the circulating tumor cells inside the blood vessels adhere to the cell monolayer of the blood vessel wall and passes through it, which allows them to invade different organs and complete metastasis. In this process, it is relevant to understand how the adhesions between cells that form the endothelial monolayer are b…
▽ More
Cell extravasation is a crucial step of the metastatic cascade. In this process, the circulating tumor cells inside the blood vessels adhere to the cell monolayer of the blood vessel wall and passes through it, which allows them to invade different organs and complete metastasis. In this process, it is relevant to understand how the adhesions between cells that form the endothelial monolayer are broken, resulting in intra-cellular gaps through which tumor cells are able to extravasate the blood vessel wall.
Within this process, we focus on studying the dynamics of cell-cell junctions rupture produced in the endothelial monolayer by the effect of Calcium waves. The regulation of this monolayer is of vital importance, not only in metastasis, but also in diseases such as pulmonary edema or atherosclerosis.
In order to understand this rupture dynamics in greater depth, we propose a hybrid model that simulates endothelial cells as \textcolor{black}{an} elastic material and cell-cell adhesions of the monolayer by means of a catch bond law.
We study the effects that the cell contraction caused by a Calcium wave presents on the endothelial monolayer depending on the diameter of the blood vessel. For this purpose, we develop a three-dimensional model to study the effect of the different blood vessel diameters.
The results indicate that there are greater tractions on the joints located in vertices common to several cells. This led to the formation of openings in the endothelial monolayer, through which extravasation of tumor cells could occur. For the different geometries studied, no significant effect of the blood vessel diameter on the rupture of the adhesions of monolayer is observed.
△ Less
Submitted 29 November, 2019;
originally announced November 2019.
-
Renal Parenchymal Area and Kidney Collagen Content
Authors:
Jake A. Nieto,
Janice Zhu,
Bin Duan,
Jingsong Li,
Ping Zhou,
Latha Paka,
Michael A. Yamin,
Itzhak D. Goldberg,
Prakash Narayan
Abstract:
The extent of renal scarring in chronic kidney disease (CKD) can only be ascertained by highly invasive, painful and sometimes risky tissue biopsy. Interestingly, CKD-related abnormalities in kidney size can often be visualized using ultrasound. Nevertheless, not only does the ellipsoid formula used today underestimate true renal size but also the relation governing renal size and collagen content…
▽ More
The extent of renal scarring in chronic kidney disease (CKD) can only be ascertained by highly invasive, painful and sometimes risky tissue biopsy. Interestingly, CKD-related abnormalities in kidney size can often be visualized using ultrasound. Nevertheless, not only does the ellipsoid formula used today underestimate true renal size but also the relation governing renal size and collagen content remains unclear. We used coronal kidney sections from healthy mice and mice with renal disease to develop a new technique for estimating the renal parenchymal area. While treating the kidney as an ellipse with the major axis the polar distance, this technique involves extending the minor axis into the renal pelvis. The calculated renal parenchymal area is remarkably similar to the measured area. Biochemically determined kidney collagen content revealed a strong and positive correlation with the calculated renal parenchymal area. The extent of renal scarring, i.e. kidney collagen content, can now be computed by making just two renal axial measurements which can easily be accomplished via noninvasive imaging of this organ.
△ Less
Submitted 10 November, 2016; v1 submitted 7 November, 2016;
originally announced November 2016.
-
An Empirical Biomarker-based Calculator for Autosomal Recessive Polycystic Kidney Disease - The Nieto-Narayan Formula
Authors:
Jake A. Nieto,
Michael A. Yamin,
Itzhak D. Goldberg,
Prakash Narayan
Abstract:
Autosomal polycystic kidney disease (ARPKD) is associated with progressive enlargement of the kidneys fuelled by the formation and expansion of fluid-filled cysts. The disease is congenital and children that do not succumb to it during the neonatal period will, by age 10 years, more often than not, require nephrectomy+renal replacement therapy for management of both pain and renal insufficiency. S…
▽ More
Autosomal polycystic kidney disease (ARPKD) is associated with progressive enlargement of the kidneys fuelled by the formation and expansion of fluid-filled cysts. The disease is congenital and children that do not succumb to it during the neonatal period will, by age 10 years, more often than not, require nephrectomy+renal replacement therapy for management of both pain and renal insufficiency. Since increasing cystic index (CI; percent of kidney occupied by cysts) drives both renal expansion and organ dysfunction, management of these patients, including decisions such as elective nephrectomy and prioritization on the transplant waitlist, could clearly benefit from serial determination of CI. So also, clinical trials in ARPKD evaluating the efficacy of novel drug candidates could benefit from serial determination of CI. Although ultrasound is currently the imaging modality of choice for diagnosis of ARPKD, its utilization for assessing disease progression is highly limited. Magnetic resonance imaging or computed tomography, although more reliable for determination of CI, are expensive, time-consuming and somewhat impractical in the pediatric population. Using a well-established mammalian model of ARPKD, we undertook a big data-like analysis of minimally- or non-invasive serum and urine biomarkers of renal injury/dysfunction to derive a family of equations for estimating CI. We then applied a signal averaging protocol to distill these equations to a single empirical formula for calculation of CI. Such a formula will eventually find use in identifying and monitoring patients at high risk for progressing to end-stage renal disease and aid in the conduct of clinical trials.
△ Less
Submitted 26 July, 2016; v1 submitted 25 July, 2016;
originally announced July 2016.
